The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

The annual meeting of the American College of Allergy, Asthma & Immunology was held from Oct. 24 to 28 in Boston, drawing ...

A research review published in Human Genomics revealed that darker skin tones can affect certain medications' safety and ...

Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...

Positive results were announced from the ECZTEND extension study of Adbry in atopic dermatitis who took part in a previous parent trial.